Depression: Mind and Body (Vol. 3, No. 4)

Faculty

This activity has 9 faculty members associated with it.
Click Here to View All

Charles F. Caley, PharmD, BCPP
Associate Clinical Professor of Pharmacy Practice
University of Connecticut School of Pharmacy
Clinical Psychopharmacology Consultant, Burlingame Center for Psychiatric Research and Education
The Institute of Living
Hartford Hospital

John W. Goethe, MD
Director, Burlingame Center for Psychiatric Research and Education
Institute of Living
Hartford Hospital

Tracy L. Greer, PhD
Assistant Professor, Department of Psychiatry
Mood Disorders Research Program and Clinic
University of Texas Southwestern Medical Center at Dallas

Abby L. Mulkeen, MD
Resident in Psychiatry
Yale-New Haven Hospital

Sunanda Muralee, MD
Co-Organizer, Cross-Cultural Psychiatry
Department of Psychiatry
Yale University School of Medicine

Bonnie L. Szarek, RN
Research Nurse and Project Coordinator, Burlingame Center for Psychiatric Research and Education
Institute of Living
Hartford Hospital

Rajesh R. Tampi, MD
Director, Geriatric Psychiatry Fellowship Program
Yale University School of Medicine
Assistant Professor and Co-Service Manager, Geriatric Services
Yale-New Haven Psychiatric Hospital

Madhukar H. Trivedi, MD
Professor of Psychiatry
Director, Mood Disorders Research Program and Clinic
University of Texas Southwestern Medical Center

Kristina F. Zdanys, BA
Research Assistant, Alzheimer’s Disease Research Unit
Yale School of Medicine

Needs Statement

Depression: Mind and Body, a CME-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of depression. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that will have most impact on their day-today practice and is designed to provide management options
for clinicians to allow them to better diagnose and treat patients with depression.

Each issue of Depression: Mind and Body will present carefully constructed leading (review) articles, written by practicing psychologists, and intended to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editor-in-Chief and readers. This issue of Depression: Mind and Body presents three such leading articles.

Target Audience

This activity is designed to meet the educational needs of psychiatrists and other clinicians involved in the management of patients with psychiatric disorders.

Objectives

After reading the article the reader should be able to discuss:
1. The different criteria used to identify metabolic syndrome in patients with depression;
2. The possible relationships between different antidepressant medications and metabolic syndrome;
3. The clinical implications of the metabolic syndrome in depressed patients and recommendations to deal with counteract these effects;
4. Tools specifically designed for elderly patients with depression;
5. Tools not specifically designed for, but commonly used in, depression studies in the elderly;
6. Tools specifically designed for the elderly, but not to rate depression alone;
7. Tools not specific to the elderly or for rating depression, but commonly used in depression studies in the elderly;
8. Exercise as a monotherapy and as an augmentation or combination treatment and the limitations of the supporting
research trials;
9. Neurobiological support for the use of exercise in mood disorders;
10. Psychological and psychosocial factors influencing exercise as a treatment for mood disorders and;
11. Clinical use and research design recommendations for investigating the effects of exercise on mood disorders.

Accreditation

Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Remedica Medical Education. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit actually spent in the educational activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

Dr. Goethe has received grants from Astra Zeneca, NIH, and Pfizer Pharmaceuticals.

Dr. Caley is a member of the advisory board for Eli Lilly and Company.

Mrs. Szarek has no relevant financial relationships to disclose.

Drs. Mulkeen, Zdanys, Muralee and Tampi have no relevant financial interests to disclose.

Dr. Trivedi has relationships with Abbott Laboratories, Inc., Abdi Brahim, Akzo (Organon Pharmaceuticals Inc.), AstraZeneca, Bayer, Bristol-Myers Squibb Company, Cephalon, Inc., Corcept Therapeutics, Inc., Cyberonics, Inc., Eli Lilly & Company, Fabre-Kramer Pharmaceuticals, Inc., Forest Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceutica Products, L.P., Johnson & Johnson PRD, Meade Johnson, Merck, NIMH, NARSD, Neuronetics, Novartis, Parke-Davis Pharmaceuticals, Inc., Pfizer Inc., Pharmacia & Upjohn, Predix Pharmaceuticals, Sepracor, Solvay Pharmaceuticals, Inc., VantagePoint, Wyeth-Ayerst Laboratories.

Dr. Greer has received research support from the NARSD.

Disclosures from all editorial staff can be found on the inside cover of the PDF.

Activity Sponsorship